Merger Model & Accretion/Dilution Analysis
A merger model is the financial framework that evaluates how an acquisition impacts the acquirer's earnings per share (EPS). This guide covers how to build robust merger models, analyze accretion/dilution, and evaluate different deal structures and financing scenarios.
What is a Merger Model?
Definition: A merger model is a financial model that combines two companies' financial statements to analyze the impact of an acquisition on the acquirer's pro forma earnings, particularly EPS accretion or dilution.
Core Purpose: Determine whether the transaction is accretive (increases EPS) or dilutive (decreases EPS) to the acquirer's shareholders.
Key Outputs:
- Pro Forma Income Statement - Combined company financials
- Sources & Uses - Deal financing structure
- EPS Impact - Accretion/dilution analysis
- Returns Analysis - IRR and ROIC
- Credit Metrics - Leverage ratios and coverage
While DCF analysis determines what you should pay based on intrinsic value, a merger model tells you what you can pay while maintaining earnings accretion. These are complementary but distinct analyses.
When to Use Merger Models
Use merger models when:
- Evaluating public company acquisitions
- Acquirer's stock is the primary currency
- Board/shareholders care about EPS impact
- Analyzing alternative financing structures
- Negotiating purchase price and terms
- Modeling earnouts or contingent payments
Critical for:
- Public company M&A
- Large strategic acquisitions
- Stock-heavy deal structures
- Transactions requiring shareholder approval
Merger Model Components
1. The Three Core Sections
Sources & Uses
Transaction Financing
How will the deal be funded? Cash, stock, debt, or combination? Includes purchase price allocation and transaction costs.
Pro Forma Financials
Combined Company
Consolidated income statement, balance sheet, and cash flow statement reflecting the combined entity with purchase accounting adjustments.
Accretion/Dilution
EPS Impact Analysis
Calculate standalone vs. pro forma EPS to determine if the deal is accretive (increases EPS) or dilutive (decreases EPS).
2. Key Assumptions
Every merger model requires:
Transaction Assumptions:
- Purchase price and structure
- Form of consideration (cash, stock, mix)
- Transaction and financing costs
- Expected closing date
- Purchase price allocation
Operating Assumptions:
- Standalone financial projections for both companies
- Revenue synergies (if any)
- Cost synergies and timing
- Integration costs
- Tax rate and structure
Financing Assumptions:
- Debt capacity and terms
- Interest rates and amortization
- Stock price for acquirer
- Exchange ratio (if stock deal)
- New share issuance
Step-by-Step Merger Model Construction
Step 1: Gather Financial Information
For Acquirer:
- Historical financial statements (3-5 years)
- Current share count and treasury stock method details
- Current stock price and trading multiples
- Existing debt schedule and terms
- Current credit metrics and rating
- Standalone financial projections
For Target:
- Historical financial statements
- Quality of earnings (QofE) analysis
- Management projections
- Current capital structure
- Working capital requirements
- Tax attributes (NOLs, basis, etc.)
Example Data Gathering:
ACQUIRER (BuyerCo)
Current Stock Price: $45.00
Shares Outstanding: 100M shares
Market Cap: $4,500M
Current Year EPS: $3.00
Next Year Est. EPS: $3.30
Existing Debt: $500M
TARGET (TargetCo)
Purchase Price: $1,500M
Current Revenue: $400M
Current EBITDA: $80M
Current Net Income: $45M
Existing Debt: $100M
Existing Cash: $50M
Step 2: Build Sources & Uses Table
The Sources & Uses table shows how the transaction is financed.
Uses of Funds (What You're Paying For):
Purchase Equity Value
+ Refinance Target Debt
+ Transaction Fees
+ Financing Fees
= Total Uses
Sources of Funds (How You're Paying):
New Debt
+ Acquirer Stock Issued
+ Cash from Balance Sheet
= Total Sources
Must Balance: Total Sources = Total Uses
Complete Example:
| USES OF FUNDS | $ Millions | % |
|---|---|---|
| Purchase Equity Value | $1,500 | 92.0% |
| Refinance Target Debt | $100 | 6.1% |
| Transaction Fees (2%) | $30 | 1.8% |
| TOTAL USES | $1,630 | 100.0% |
| SOURCES OF FUNDS | $ Millions | % |
|---|---|---|
| New Term Loan | $600 | 36.8% |
| Acquirer Stock (@ $45.00) | $900 | 55.2% |
| Cash from Balance Sheet | $130 | 8.0% |
| TOTAL SOURCES | $1,630 | 100.0% |
Key Calculations:
Enterprise Value = Equity Value + Debt - Cash
= $1,500M + $100M - $50M
= $1,550M
Implied Multiples:
EV / Revenue = $1,550M / $400M = 3.9x
EV / EBITDA = $1,550M / $80M = 19.4x
New Shares Issued = Stock Consideration / Stock Price
= $900M / $45.00 = 20.0M shares
Pro Forma Shares = Acquirer Shares + New Shares
= 100M + 20M = 120M shares
Step 3: Purchase Price Allocation (PPA)
Purchase price allocation determines how the purchase price is allocated on the balance sheet.
Purchase Price Allocation Formula:
Purchase Price
- Fair Value of Net Assets Acquired
= Goodwill
Key Steps:
- Identify Acquired Assets and Liabilities
- Fair Value Adjustments - Revalue to fair market value
- Identify Intangible Assets - Customer relationships, technology, brand
- Calculate Goodwill - Residual amount
Example Purchase Price Allocation:
Purchase Price: $1,500M
NET ASSETS ACQUIRED:
Current Assets $150M
PP&E (at fair value) $200M
Identified Intangibles:
- Customer Relationships (10yr) $250M
- Technology/IP (5yr) $150M
- Trade Names (indefinite) $50M
Current Liabilities ($100M)
Deferred Tax Liability (25% on intangibles) ($112M)
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
Fair Value of Net Assets $588M
GOODWILL = $1,500M - $588M = $912M
Tax Impact: Intangibles create deferred tax liability because book basis โ tax basis (often not tax deductible)
Step 4: Build Pro Forma Income Statement
Combine both companies' income statements with adjustments.
Pro Forma Adjustments:
- Revenue - Standalone projections + synergies (if applicable)
- Cost Synergies - Cost savings from integration
- D&A - New depreciation/amortization from PPA
- Interest Expense - New debt service
- Share Count - Include new shares issued
Complete Pro Forma Example:
| Pro Forma Income Statement (Year 1) | BuyerCo | TargetCo | Adjustments | Pro Forma |
|---|---|---|---|---|
| Revenue | $2,000 | $400 | โ | $2,400 |
| Cost of Revenue | (800) | (200) | โ | (1,000) |
| Gross Profit | 1,200 | 200 | โ | 1,400 |
| Operating Expenses | (600) | (120) | 30 | (690) |
| Cost Synergies | โ | โ | +$30M | โ |
| D&A | (100) | (20) | (50) | (170) |
| PPA Intangible Amort. | โ | โ | -$50M | โ |
| EBIT | 500 | 60 | (20) | 540 |
| Interest Expense | (25) | (5) | (30) | (60) |
| New Debt Interest @ 5% | โ | โ | -$30M | โ |
| Pre-Tax Income | 475 | 55 | (50) | 480 |
| Taxes @ 25% | (119) | (14) | 13 | (120) |
| Net Income | $356 | $41 | ($37) | $360 |
Key Adjustments Explained:
- Cost Synergies (+$30M): Elimination of redundant roles, facilities, systems
- PPA Amortization (-$50M): New intangible assets amortization
Customer Relationships: $250M / 10 years = $25M/year Technology: $150M / 5 years = $30M/year Total Annual Amortization = $55M (rounded to $50M shown) - New Interest Expense (-$30M): $600M debt ร 5.0% = $30M/year
- Tax Benefit (+$13M): Tax shield on incremental interest expense
Step 5: Calculate Accretion/Dilution
The Critical Question: Does the deal increase or decrease EPS?
EPS Calculation:
EPS = Net Income / Weighted Average Shares Outstanding
Accretion/Dilution Formula:
Accretion/(Dilution) % = (Pro Forma EPS - Standalone EPS) / Standalone EPS
Complete Accretion/Dilution Analysis:
| Metric | BuyerCo Standalone | Pro Forma Combined | Change |
|---|---|---|---|
| Net Income ($M) | $356 | $360 | +$4 |
| Shares Outstanding (M) | 100.0 | 120.0 | +20.0 |
| EPS | $3.56 | $3.00 | ($0.56) |
| Accretion/(Dilution) | โ | โ | (15.7%) |
Interpretation:
Accretion/Dilution = ($3.00 - $3.56) / $3.56 = -15.7%
Result: The deal is 15.7% DILUTIVE in Year 1
A dilutive deal can still create shareholder value if:
โข The acquisition becomes accretive in future years
โข Strategic value justifies near-term dilution
โข Synergies create long-term value exceeding dilution
โข Target's growth rate exceeds acquirer's growth rate
Step 6: Multi-Year Accretion/Dilution
Show how accretion/dilution evolves over time as synergies ramp and financing costs are paid down.
Multi-Year Analysis:
| Metric ($M except EPS) | Year 1 | Year 2 | Year 3 |
|---|---|---|---|
| STANDALONE BUYERCO | |||
| Net Income | $356 | $392 | $431 |
| Shares Outstanding | 100.0 | 100.0 | 100.0 |
| Standalone EPS | $3.56 | $3.92 | $4.31 |
| PRO FORMA COMBINED | |||
| Pro Forma Net Income | $360 | $450 | $540 |
| Pro Forma Shares | 120.0 | 120.0 | 120.0 |
| Pro Forma EPS | $3.00 | $3.75 | $4.50 |
| ACCRETION/(DILUTION) ANALYSIS | |||
| EPS Difference | ($0.56) | ($0.17) | $0.19 |
| Accretion/(Dilution) % | (15.7%) | (4.3%) | +4.4% |
Key Insights:
- Year 1: 15.7% dilutive due to high amortization and interest costs
- Year 2: 4.3% dilutive as synergies ramp up
- Year 3: 4.4% accretive as full synergies realized and growth accelerates
Synergy Ramp Assumption:
Year 1: 50% of run-rate synergies ($30M ร 50% = $15M realized)
Year 2: 100% of run-rate synergies ($30M fully realized)
Year 3: Full synergies + faster growth from integration
Step 7: Alternative Deal Structures
Model multiple financing scenarios to understand trade-offs.
Scenario Comparison:
| Scenario | All Cash | 50/50 Mix | All Stock |
|---|---|---|---|
| SOURCES ($M) | |||
| Debt | $1,200 | $600 | $0 |
| Stock | $0 | $900 | $1,500 |
| Cash | $430 | $130 | $130 |
| NEW SHARES ISSUED | |||
| New Shares (M) | 0.0 | 20.0 | 33.3 |
| Pro Forma Shares (M) | 100.0 | 120.0 | 133.3 |
| YEAR 1 EPS IMPACT | |||
| Pro Forma Net Income | $307 | $360 | $397 |
| Pro Forma EPS | $3.07 | $3.00 | $2.98 |
| Accretion/(Dilution) | (13.8%) | (15.7%) | (16.3%) |
| CREDIT METRICS | |||
| Total Debt / EBITDA | 6.4x | 3.8x | 1.6x |
| Interest Coverage (EBIT/Int) | 7.3x | 9.0x | 21.6x |
Trade-offs Analysis:
All Cash/Debt:
- โ No dilution from new shares
- โ Existing shareholders maintain ownership %
- โ Highest interest expense drag
- โ Leveraged balance sheet
- โ Credit rating risk
50/50 Mix (Base Case):
- โ Balanced approach
- โ Manageable leverage
- โ Moderate dilution
- โ Some share dilution
- โ Some interest expense
All Stock:
- โ No debt, pristine balance sheet
- โ Preserves financial flexibility
- โ Highest net income (no interest)
- โ Significant dilution (33% more shares)
- โ Ownership dilution for existing shareholders
- โ Deal value fluctuates with stock price
Advanced Merger Model Considerations
Treasury Stock Method for Options/RSUs
When calculating pro forma shares, include dilutive securities.
Treasury Stock Method:
Diluted Shares = Options Outstanding - (Options ร Strike Price) / Current Price
Example:
10M options outstanding @ $30 strike
Current stock price: $45
Diluted Shares = 10M - (10M ร $30) / $45
= 10M - 6.7M
= 3.3M additional shares
Convertible Debt Treatment
If-Converted Method:
- Add back interest expense (after-tax)
- Add converted shares to denominator
Example:
$100M convertible debt @ 3% interest, converts to 2M shares
Add back to numerator: $100M ร 3% ร (1 - 25% tax) = $2.25M
Add to denominator: 2M shares
Purchase Price True-Up
Model potential purchase price adjustments:
Working Capital Adjustment:
Target Working Capital: $50M
Actual at Close: $47M
Purchase Price Reduction: $3M
Earnout Modeling:
Base Purchase Price: $1,500M
Earnout (Year 2): $100M if EBITDA > $90M
Probability-Weighted: $100M ร 70% = $70M
Model as contingent liability, expense over earnout period
Synergy Modeling Deep Dive
Cost Synergies (More certain, faster to realize):
Headcount Reduction
Redundant roles: 150 positions Avg. fully-loaded cost: $150K Annual savings: 150 ร $150K = $22.5M Severance cost: 150 ร $100K = $15M (one-time)Facility Consolidation
Duplicate offices: 3 locations Annual rent savings: $5M One-time exit costs: $8MTechnology/Vendor Consolidation
Duplicate SaaS subscriptions: $2M/year Professional services savings: $1M/year
Revenue Synergies (Less certain, slower to realize):
Cross-Selling
Target customer base: 5,000 customers Cross-sell rate: 15% Avg. deal size: $50K Year 1 Revenue: 5,000 ร 15% ร $50K ร 50% (ramp) = $18.8M Year 2 Revenue: 5,000 ร 15% ร $50K = $37.5MProduct Bundling
Price increase from bundle: 10% Affected revenue: $200M Incremental revenue: $20M/year
Synergy Capture Rate:
Year 1 Year 2 Year 3
Cost Synergies 50% 100% 100%
Revenue Syn. 20% 50% 80%
Balance Sheet Modeling
Don't forget the pro forma balance sheet!
Key Line Items:
Assets:
- Cash (post-transaction)
- Working capital (combined)
- PP&E (fair value adjustments)
- Intangible assets (PPA)
- Goodwill
Liabilities:
- New debt balances
- Deferred tax liabilities (from PPA)
- Assumed liabilities
Equity:
- Common stock (par value of new shares)
- APIC (additional paid-in capital)
- Retained earnings
Example Balance Sheet Impact:
Pre-Deal Post-Deal Change
Total Assets $5,000M $7,100M +$2,100M
Total Debt $500M $1,200M +$700M
Shareholders' Equity $4,000M $5,300M +$1,300M
Debt/Equity Ratio 12.5% 22.6% +10.1 pts
Sensitivity Analysis & Scenario Modeling
Model multiple scenarios to understand deal dynamics.
Price Sensitivity
Purchase Price vs. Accretion:
| Purchase Price | $1,300M | $1,400M | $1,500M | $1,600M |
|---|---|---|---|---|
| EV / EBITDA | 16.9x | 18.1x | 19.4x | 20.6x |
| Y1 Accretion | -10.2% | -13.1% | -15.7% | -18.5% |
| Y3 Accretion | +9.1% | +6.5% | +4.4% | +1.8% |
Synergy Sensitivity
Synergies vs. Accretion (Year 3):
Cost Synergies Realized
$20M $30M $40M
Stock Price
$40 -2.1% +4.4% +10.9%
$45 -5.3% +1.2% +7.7%
$50 -8.1% -1.8% +4.7%
Break-Even Analysis
What purchase price makes deal accretion-neutral?
Target Year 1 EPS: $3.56 (standalone)
Pro Forma Shares: 120M
Required Net Income: $3.56 ร 120M = $427M
Working backwards:
Required EBITDA: $600M
Less: Target EBITDA: $80M
Implied Max Purchase EBITDA Multiple: ~17.5x
Max Purchase Price: ~$1,400M
Common Merger Model Pitfalls
1. Ignoring Transaction Costs
Problem: Forgetting fees and expenses that reduce net income or increase purchase price
Transaction Costs Include:
- Investment banker fees (1-3% of deal value)
- Legal and accounting fees ($5M-$20M)
- Due diligence costs ($2M-$5M)
- Financing fees (1-2% of debt raised)
- Consent and control change fees
Solution:
- Model all transaction costs explicitly
- Determine if costs are capitalized (added to goodwill) or expensed (reduce NI)
- Most M&A advisory fees are expensed in period incurred
Example Impact:
$1,500M deal
Transaction fees @ 2%: $30M
After-tax impact: $30M ร (1 - 25%) = $22.5M hit to Year 1 NI
EPS impact: $22.5M / 120M shares = $0.19/share
2. Incorrect Share Count Calculation
Problem: Using wrong share count or forgetting dilutive securities
Common Mistakes:
- Using basic shares instead of diluted
- Forgetting to add new shares from stock consideration
- Not accounting for treasury stock method on options
- Using wrong weighted average for partial year transactions
Solution:
Pro Forma Shares =
Acquirer Diluted Shares
+ New Shares Issued for Purchase
+ Shares from Assumed Target Options (treasury method)
- Buyback from Cash Proceeds (if applicable)
Partial Year Example:
Deal closes June 30 (mid-year)
Standalone shares: 100M (full year)
New shares: 20M (half year)
Weighted Avg = 100M + (20M ร 0.5) = 110M shares
3. Double-Counting or Missing Synergies
Problem: Including synergies incorrectly or missing negative synergies
Common Issues:
- Counting same synergy in multiple categories
- Ignoring costs to achieve synergies
- Forgetting revenue dis-synergies (customer losses)
- Over-estimating timing of realization
Solution:
- Build detailed synergy bridge
- Include integration costs and timeline
- Model negative synergies (customer churn, employee departures)
- Use conservative realization assumptions (50%/100% over 2 years)
Example Synergy Bridge:
Gross Cost Synergies Identified: $40M
- Integration costs (Year 1): ($15M)
- Realization rate (80%): ร 80%
Net Cost Synergies: $17M (run-rate)
Revenue Synergies: $25M
- Customer churn: ($5M)
- Delayed realization (Year 1): ร 30%
Net Revenue Synergies (Year 1): $6M
4. Wrong Tax Rate
Problem: Using inappropriate tax rate for pro forma entity
Issues:
- Using statutory rate instead of effective rate
- Not adjusting for non-deductible expenses
- Forgetting NOL utilization
- Ignoring international tax considerations
Solution:
- Use effective tax rate from historical financials
- Adjust for one-time items
- Model NOL usage if applicable
- Consider 163(j) interest deduction limitations
Example:
Statutory rate: 21%
State taxes: 4%
Permanent differences: +1%
Effective tax rate: 26%
NOT 21%!
5. Incorrect PPA Treatment
Problem: Wrong amortization periods or missing deferred tax impact
Common Errors:
- Amortizing goodwill (not allowed under GAAP)
- Using wrong useful lives for intangibles
- Forgetting deferred tax liability on intangibles
- Not adjusting D&A in future years
Solution:
Intangible Asset Amount Life Annual Amort
Customer Relationships $250M 10yr $25M
Technology/IP $150M 5yr $30M
Trade Names $50M Indef $0
Goodwill $912M Indef $0
Total PPA Amortization: $55M/year
Deferred Tax Liability = ($250M + $150M) ร 25% = $100M
(Reduces net assets acquired, increases goodwill)
6. Forgetting Balance Sheet Impact
Problem: Only modeling P&L, ignoring B/S and credit metrics
Solution:
- Model pro forma balance sheet
- Calculate leverage ratios (Debt/EBITDA)
- Calculate coverage ratios (EBIT/Interest)
- Ensure compliance with debt covenants
- Consider rating agency impact
7. Static Stock Price Assumption
Problem: Not stress-testing impact of stock price changes on deal value
For Stock Deals:
- Deal value fluctuates with stock price
- Fixed exchange ratio vs. fixed value collar
- Impact on accretion/dilution
Solution: Model multiple stock price scenarios
Example:
Fixed exchange ratio: 0.5 shares per target share
Target shares: 30M
Fixed shares issued: 15M
Acquirer Stock Price Deal Value Impact
$40 $600M Underpay
$45 $675M Base
$50 $750M Overpay
Consider collar: 0.45 - 0.55 ratio based on $40-$50 range
Best Practices
1. Build a Flexible Model
Model Architecture:
- Separate assumptions tab (all inputs in one place)
- Scenario dropdowns for different cases
- Data validation and error checks
- Clear color coding (blue = input, black = formula)
Key Toggles:
Purchase Price: $1,500M
Stock/Cash Mix: 60% / 40%
Synergy Realization: 50% / 100% (Y1/Y2)
Closing Date: Q2 2025
Tax Rate: 25%
2. Multiple Scenarios and Sensitivities
Build Three Core Cases:
- Base Case: Most likely scenario
- Upside Case: Optimistic but achievable
- Downside Case: Conservative scenario
Key Sensitivities:
- Purchase price (ยฑ10-20%)
- Stock price (ยฑ20%)
- Synergies (50%-150% of plan)
- Growth rates
- Financing costs
3. Link to Strategic Rationale
Beyond the Numbers:
- Why does deal make strategic sense?
- How does valuation compare to standalone DCF?
- What's the walk from DCF value to offer price?
- What are the key value creation drivers?
Strategic Value Bridge:
DCF Standalone Value: $1,200M
+ Control Premium (20%): $240M
+ PV of Cost Synergies: $180M
+ PV of Revenue Synergies: $120M
+ Strategic/Platform Value: $100M
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
Justifiable Price: $1,840M
Actual Offer: $1,500M
Margin of Safety: $340M (23%)
4. Credit and Leverage Analysis
Key Metrics to Track:
| Metric | Investment Grade Target | High Yield Target |
|---|---|---|
| Debt / EBITDA | < 3.0x | < 5.0x |
| EBIT / Interest | >> 5.0x | >> 3.0x |
| Debt / Total Cap | < 40% | < 60% |
| FCF / Debt | > 20% | > 10% |
5. Football Field Valuation Summary
Present merger model results alongside other valuation methods:
Valuation Method Low Mid High
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
DCF Analysis $1,200 $1,350 $1,500
Comparable Companies $1,150 $1,300 $1,450
Precedent Transactions $1,300 $1,450 $1,600
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
Implied Range $1,150 $1,367 $1,517
Management Target $1,500
Control Premium 15.8%
6. Returns Analysis
Calculate returns metrics beyond accretion/dilution:
Internal Rate of Return (IRR):
Year 0: Purchase Price ($1,500M)
Year 1-5: Annual FCF $100M - $180M
Year 5: Exit Value $2,100M (14x EBITDA)
IRR = 18.5%
Return on Invested Capital (ROIC):
ROIC = NOPAT / Invested Capital
Year 3 ROIC:
NOPAT: $85M
Invested Capital: $1,500M
ROIC = $85M / $1,500M = 5.7%
Target: Exceed WACC (typically 8-12%)
7. Risk-Adjusted Analysis
Probability-Weight Scenarios:
Prob EPS Weighted
Base Case 50% $3.00 $1.50
Upside 25% $3.75 $0.94
Downside 25% $2.40 $0.60
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
Expected EPS $3.04
Standalone EPS: $3.56
Expected Dilution: -14.6%
8. Board Presentation Framework
Key Slides for Board:
- Transaction Overview - Price, structure, rationale
- Strategic Fit - Why this deal, why now
- Valuation Summary - Football field
- Sources & Uses - Deal financing
- Financial Impact - Accretion/dilution
- Sensitivities - Key risk factors
- Synergy Bridge - Cost and revenue synergies
- Integration Plan - Timeline and risks
- Alternatives - Why not other targets
- Recommendation - Go/no-go with clear logic
Real-World Merger Model Example
Case Study: TechAcquirer buys CloudTarget
Deal Parameters
TechAcquirer (Buyer):
Current Stock Price: $85.00
Shares Outstanding: 500M
Market Cap: $42.5B
LTM Revenue: $10.0B
LTM EBITDA: $2.5B
LTM Net Income: $1.5B
Current EPS: $3.00
P/E Ratio: 28.3x
CloudTarget (Target):
Purchase Price: $5.0B
LTM Revenue: $800M
LTM EBITDA: $160M
LTM Net Income: $85M
Existing Debt: $200M
Cash: $100M
Deal Structure
| Sources & Uses | $ Millions |
|---|---|
| USES | |
| Purchase Equity Value | $5,000 |
| Refinance Target Debt | $200 |
| Transaction Fees (2%) | $100 |
| Total Uses | $5,300 |
| SOURCES | |
| Stock (70% @ $85.00) | $3,710 |
| New Term Loan (30%) | $1,590 |
| Total Sources | $5,300 |
New Shares Issued: $3,710M / $85.00 = 43.6M shares
Pro Forma Shares: 500M + 43.6M = 543.6M shares
Accretion/Dilution Analysis
Year 1 Pro Forma:
TechAcquirer Standalone NI: $1,500M
CloudTarget NI: $85M
Combined Pre-Synergies: $1,585M
Adjustments:
- PPA Amortization ($800M/8yr) ($100M)
- New Interest @ 5.0% ($80M)
+ Cost Synergies (50% realized) $60M
- Transaction Costs ($75M)
+ Tax Benefit @ 25% $49M
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
Pro Forma Net Income: $1,439M
Pro Forma EPS = $1,439M / 543.6M = $2.65
Standalone EPS: $3.00
Pro Forma EPS: $2.65
Accretion/(Dilution): -11.7% DILUTIVE
Year 3 Pro Forma (Full Synergies):
Pro Forma Net Income: $1,950M
Pro Forma Shares: 543.6M
Pro Forma EPS: $3.59
Standalone EPS (projected): $3.50
Accretion: +2.6% ACCRETIVE
Conclusion: Deal is dilutive in Year 1 but becomes accretive by Year 3 as synergies fully realize.
Full Merger Model Template
This section provides a complete, production-ready merger model template that can be used as-is for mid-market and large company M&A transactions. Copy this template into Excel and customize the inputs for your specific deal.
SECTION 1: Transaction Assumptions & Inputs
Use this section for all deal-specific inputs. Keep all assumptions in one place for easy scenario analysis.
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
MERGER MODEL INPUTS
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
TRANSACTION OVERVIEW
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
Deal Announcement Date: [MM/DD/YYYY]
Expected Close Date: [MM/DD/YYYY]
Transaction Structure: [Stock/Cash/Mixed]
Target Company Name: [TargetCo]
Acquirer Company Name: [AcquirerCo]
PURCHASE PRICE & CONSIDERATION
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
Purchase Equity Value ($M): $1,500
Premium to Current Price: 25.0%
Premium to 30-Day VWAP: 22.5%
Form of Consideration:
% Cash: 40.0%
% Stock: 60.0%
Total: 100.0%
Cash Consideration ($M): $600
Stock Consideration ($M): $900
IMPLIED VALUATION MULTIPLES
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
Target LTM Revenue ($M): $400
Target LTM EBITDA ($M): $80
Target LTM EBIT ($M): $60
Target Net Debt ($M): $50
(Debt $100M - Cash $50M)
Enterprise Value ($M): $1,550
(Equity Value $1,500 + Net Debt $50)
EV / LTM Revenue: 3.9x
EV / LTM EBITDA: 19.4x
EV / LTM EBIT: 25.8x
P / LTM Net Income ($45M): 33.3x
ACQUIRER INFORMATION
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
Current Stock Price: $45.00
Shares Outstanding - Basic (M): 100.0
Treasury Stock Options (M): 5.0
Diluted Shares Outstanding (M): 103.0
Market Capitalization ($M): $4,500
Current Year Est. EPS: $3.00
Next Year Est. EPS: $3.30
Current P/E Ratio: 15.0x
Existing Total Debt ($M): $500
Existing Cash ($M): $300
Net Debt ($M): $200
TARGET INFORMATION
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
Target Shares Outstanding (M): 30.0
Implied Price per Share: $50.00
Pre-Announcement Price: $40.00
Target Existing Debt ($M): $100
Target Cash ($M): $50
Target Net Debt ($M): $50
FINANCING ASSUMPTIONS
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
New Debt Issuance ($M): $600
Revolver Draw ($M): $0
Term Loan A ($M): $400
Term Loan B ($M): $200
Senior Notes ($M): $0
Weighted Average Cost of Debt: 5.00%
Revolver Rate: 4.50%
Term Loan A Rate: 4.75%
Term Loan B Rate: 5.50%
Senior Notes Rate: 5.25%
Target Debt to Refinance ($M): $100
Cash from Balance Sheet ($M): $130
New Stock Issuance:
Dollar Amount ($M): $900
Stock Price for Issuance: $45.00
New Shares Issued (M): 20.0
Pro Forma Shares Outstanding (M): 123.0
TRANSACTION COSTS & FEES
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
M&A Advisory Fees (% of Equity Value): 2.0%
M&A Advisory Fees ($M): $30.0
Legal & Accounting ($M): $15.0
Due Diligence Costs ($M): $3.0
Financing Fees (% of Debt): 1.5%
Financing Fees ($M): $9.0
Other Transaction Costs ($M): $3.0
Total Transaction Costs ($M): $60.0
Treatment of Transaction Costs:
Expensed in Current Period: $48.0
Capitalized (Debt Fees): $9.0
Seller-Paid Fees: $3.0
TAX ASSUMPTIONS
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
Acquirer Effective Tax Rate: 25.0%
Target Effective Tax Rate: 25.0%
Pro Forma Tax Rate: 25.0%
Tax Structure: [Taxable/Tax-Free]
Target NOLs ($M): $0
Annual NOL Limitation (ยง382): $0
SYNERGY ASSUMPTIONS
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
COST SYNERGIES (Run-Rate):
Headcount Reduction:
Positions Eliminated: 150
Avg. Fully-Loaded Cost ($K): $150
Annual Savings ($M): $22.5
Facility Consolidation ($M): $5.0
Vendor/Technology Consolidation ($M): $3.0
Other Operating Expense Savings ($M): $2.5
Total Run-Rate Cost Synergies ($M): $33.0
Cost Synergy Realization:
Year 1 (% of run-rate): 50%
Year 2 (% of run-rate): 100%
Year 3+ (% of run-rate): 100%
One-Time Costs to Achieve:
Severance ($M): $15.0
Facility Exit Costs ($M): $8.0
System Integration ($M): $12.0
Other Integration Costs ($M): $5.0
Total Integration Costs ($M): $40.0
Integration Cost Timing:
Year 1: 75%
Year 2: 25%
REVENUE SYNERGIES (Run-Rate):
Cross-Selling Revenue ($M): $15.0
Product Bundling Uplift ($M): $8.0
Market Expansion ($M): $5.0
Total Run-Rate Revenue Synergies ($M): $28.0
Revenue Synergy Realization:
Year 1 (% of run-rate): 20%
Year 2 (% of run-rate): 50%
Year 3 (% of run-rate): 80%
Year 4+ (% of run-rate): 100%
Incremental Margin on Revenue Synergies: 60%
DIS-SYNERGIES:
Customer Churn ($M): $10.0
Key Employee Departures Impact ($M): $5.0
Total Dis-Synergies ($M): $15.0
WACC / DISCOUNT RATE ASSUMPTIONS
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
Risk-Free Rate (10Y Treasury): 4.0%
Beta (Levered): 1.2
Market Risk Premium: 5.5%
Size Premium: 2.0%
Cost of Equity: 12.6%
= Rf + (Beta ร MRP) + Size Premium
= 4.0% + (1.2 ร 5.5%) + 2.0%
After-Tax Cost of Debt: 3.75%
= 5.0% ร (1 - 25%)
Target Capital Structure:
Debt / (Debt + Equity): 20%
Equity / (Debt + Equity): 80%
WACC: 11.1%
= (80% ร 12.6%) + (20% ร 3.75%)
SECTION 2: Sources & Uses of Funds
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
SOURCES & USES
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
USES OF FUNDS $M % of Total
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
Purchase Target Equity $1,500 92.0%
Repay/Refinance Target Debt $100 6.1%
Transaction Fees & Expenses $30 1.8%
Financing Fees $0 0.0%
โโโโโโโโโโโโโโโโโโโโโ
TOTAL USES $1,630 100.0%
SOURCES OF FUNDS $M % of Total
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
New Term Loan $600 36.8%
Acquirer Stock Issued $900 55.2%
Cash from Balance Sheet $130 8.0%
Revolver Draw $0 0.0%
โโโโโโโโโโโโโโโโโโโโโ
TOTAL SOURCES $1,630 100.0%
Check (must = $0): $0 โ
TRANSACTION SUMMARY METRICS
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
Total Transaction Value ($M): $1,630
Enterprise Value ($M): $1,550
Equity Value ($M): $1,500
Net Debt Assumed ($M): $50
Purchase Price per Target Share: $50.00
Target Shares Acquired (M): 30.0
Premium Paid:
vs. Unaffected Price ($40): 25.0%
vs. 30-Day VWAP ($41): 22.0%
vs. 52-Week High ($48): 4.2%
New Acquirer Shares Issued (M): 20.0
Exchange Ratio (per target share): 0.667x
Fixed Collar Range: $42 - $48
Pro Forma Ownership:
Existing Acquirer Shareholders: 83.7%
Former Target Shareholders: 16.3%
SECTION 3: Purchase Price Allocation (PPA)
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
PURCHASE PRICE ALLOCATION (PPA)
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
PURCHASE PRICE $M
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
Total Consideration Paid $1,500
LESS: FAIR VALUE OF NET ASSETS ACQUIRED
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
ASSETS:
Current Assets:
Cash & Equivalents $50
Accounts Receivable $60
Inventory $30
Other Current Assets $10
Total Current Assets $150
Fixed Assets (PP&E):
Book Value $150
Fair Value Step-Up $50
Fair Value of PP&E $200
Identified Intangible Assets:
Customer Relationships
Fair Value $250
Useful Life (years) 10
Annual Amortization $25
Developed Technology/IP
Fair Value $150
Useful Life (years) 5
Annual Amortization $30
Trade Names & Trademarks
Fair Value $50
Useful Life Indefinite
Annual Amortization $0
Non-Compete Agreements
Fair Value $20
Useful Life (years) 3
Annual Amortization $7
Total Identified Intangibles $470
Total Annual Amortization $62
Other Assets $10
TOTAL ASSETS ACQUIRED $830
LIABILITIES:
Current Liabilities:
Accounts Payable $50
Accrued Expenses $30
Deferred Revenue $20
Total Current Liabilities ($100)
Long-Term Liabilities:
Deferred Tax Liability (on intangibles)
Tax Rate 25%
Taxable Intangibles $470
DTL Created ($118)
Other Long-Term Liabilities ($10)
TOTAL LIABILITIES ASSUMED ($228)
NET ASSETS ACQUIRED (Fair Value) $602
GOODWILL CALCULATION
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
Purchase Price $1,500
Less: Fair Value of Net Assets ($602)
โโโโโโ
GOODWILL $898
Goodwill as % of Purchase Price: 59.9%
ANNUAL AMORTIZATION EXPENSE SCHEDULE
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
Y1 Y2 Y3 Y4 Y5 Total
Customer Relationships $25 $25 $25 $25 $25 $125
Technology/IP $30 $30 $30 $30 $30 $150
Trade Names $0 $0 $0 $0 $0 $0
Non-Compete $7 $7 $7 $0 $0 $20
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
Total PPA Amortization $62 $62 $62 $55 $55 $295
Note: Goodwill and indefinite-lived intangibles are not
amortized but subject to annual impairment testing.
SECTION 4: Pro Forma Income Statement (5-Year Projection)
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
PRO FORMA INCOME STATEMENT
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
($M except per share data) LTM Year 1 Year 2 Year 3 Year 4 Year 5
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
ACQUIRER STANDALONE
Revenue $2,000 $2,200 $2,420 $2,662 $2,928 $3,221
% Growth โ 10.0% 10.0% 10.0% 10.0% 10.0%
COGS (800) (880) (968) (1,065) (1,171) (1,288)
Gross Profit 1,200 1,320 1,452 1,597 1,757 1,933
Gross Margin % 60.0% 60.0% 60.0% 60.0% 60.0% 60.0%
Operating Expenses (600) (638) (665) (692) (721) (750)
D&A (100) (110) (121) (133) (146) (161)
EBIT 500 572 666 772 890 1,022
EBIT Margin % 25.0% 26.0% 27.5% 29.0% 30.4% 31.7%
Interest Expense (25) (25) (25) (24) (23) (22)
Pre-Tax Income 475 547 641 748 867 1,000
Taxes @ 25% (119) (137) (160) (187) (217) (250)
Net Income $356 $410 $481 $561 $650 $750
Diluted Shares (M) 103.0 103.0 103.0 103.0 103.0 103.0
EPS - Standalone $3.46 $3.98 $4.67 $5.45 $6.31 $7.28
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
TARGET STANDALONE
Revenue $400 $460 $529 $608 $699 $804
% Growth โ 15.0% 15.0% 15.0% 15.0% 15.0%
COGS (200) (230) (265) (304) (350) (402)
Gross Profit 200 230 264 304 349 402
Gross Margin % 50.0% 50.0% 50.0% 50.0% 50.0% 50.0%
Operating Expenses (120) (129) (138) (146) (154) (161)
D&A (20) (21) (22) (23) (24) (25)
EBIT 60 80 104 135 171 216
EBIT Margin % 15.0% 17.4% 19.7% 22.2% 24.5% 26.9%
Interest Expense (5) (5) (5) (5) (5) (5)
Pre-Tax Income 55 75 99 130 166 211
Taxes @ 25% (14) (19) (25) (33) (42) (53)
Net Income $41 $56 $74 $98 $125 $158
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
PRO FORMA ADJUSTMENTS
PPA Amortization โ (62) (62) (62) (55) (55)
New Interest Expense โ (30) (30) (29) (28) (27)
Eliminate Target Interest โ 5 5 5 5 5
Cost Synergies Realized โ 17 33 33 33 33
Revenue Synergies (60% margin) โ 3 8 13 17 17
Dis-Synergies โ (15) (8) (3) 0 0
Integration Costs โ (30) (10) 0 0 0
Transaction Costs (expensed) โ (48) 0 0 0 0
Tax Impact of Adjustments @ 25% โ 30 16 11 8 7
Total Pro Forma Adjustments โ (130) (48) (32) (20) (20)
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
PRO FORMA COMBINED
Revenue $2,400 $2,660 $2,949 $3,270 $3,627 $4,025
% Growth YoY โ 10.8% 10.9% 10.9% 10.9% 11.0%
Combined Gross Profit 1,400 1,550 1,716 1,901 2,106 2,335
Gross Margin % 58.3% 58.3% 58.2% 58.1% 58.1% 58.0%
Combined Operating Expenses (720) (750) (775) (805) (842) (878)
Combined D&A (120) (131) (143) (156) (170) (186)
PPA Amortization โ (62) (62) (62) (55) (55)
Cost Synergies โ 17 33 33 33 33
Integration Costs โ (30) (10) 0 0 0
Pro Forma EBIT 560 594 759 911 1,072 1,249
EBIT Margin % 23.3% 22.3% 25.7% 27.9% 29.6% 31.0%
Pro Forma Interest Expense (30) (50) (50) (48) (46) (44)
Pro Forma Pre-Tax Income 530 544 709 863 1,026 1,205
Pro Forma Taxes @ 25% (133) (136) (177) (216) (257) (301)
PRO FORMA NET INCOME $397 $408 $532 $647 $770 $904
Pro Forma Diluted Shares (M) 123.0 123.0 123.0 123.0 123.0 123.0
PRO FORMA EPS $3.23 $3.32 $4.33 $5.26 $6.26 $7.35
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
ACCRETION / (DILUTION) ANALYSIS
Standalone EPS $3.46 $3.98 $4.67 $5.45 $6.31 $7.28
Pro Forma EPS $3.23 $3.32 $4.33 $5.26 $6.26 $7.35
Difference ($0.23) ($0.66) ($0.34) ($0.19) ($0.05) $0.07
Accretion / (Dilution) % (6.6%) (16.6%) (7.3%) (3.5%) (0.8%) 1.0%
Status DILUTIVE DILUTIVE DILUTIVE DILUTIVE DILUTIVE ACCRETIVE
SECTION 5: Pro Forma Balance Sheet
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
PRO FORMA BALANCE SHEET (Post-Close)
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
($M) Acquirer Target Adj. Pro Forma
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
ASSETS
Current Assets:
Cash & Equivalents $300 $50 ($170) $180
Accounts Receivable 400 60 0 460
Inventory 200 30 0 230
Other Current Assets 100 10 0 110
Total Current Assets 1,000 150 (170) 980
Fixed Assets (PP&E):
Gross PP&E 2,000 150 50 2,200
Accumulated Depreciation (800) 0 0 (800)
Net PP&E 1,200 150 50 1,400
Intangible Assets:
Customer Relationships 0 0 250 250
Technology/IP 0 0 150 150
Trade Names 0 0 50 50
Non-Compete 0 0 20 20
Total Intangibles 0 0 470 470
Goodwill 500 0 898 1,398
Other Assets 100 10 0 110
TOTAL ASSETS $2,800 $310 $1,248 $4,358
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
LIABILITIES
Current Liabilities:
Accounts Payable $200 $50 $0 $250
Accrued Expenses 150 30 0 180
Short-Term Debt 50 0 0 50
Deferred Revenue 0 20 0 20
Total Current Liabilities 400 100 0 500
Long-Term Debt:
Existing Acquirer Debt 450 0 0 450
Target Debt (refinanced) 0 100 (100) 0
New Debt 0 0 600 600
Total Long-Term Debt 450 100 500 1,050
Deferred Tax Liability 100 0 118 218
Other Liabilities 50 10 0 60
TOTAL LIABILITIES $1,000 $210 $518 $1,728
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
SHAREHOLDERS' EQUITY
Common Stock (par) $10 $3 $2 $12
Additional Paid-In Capital 600 37 898 1,535
Retained Earnings 1,190 60 (170) 1,080
Treasury Stock 0 0 0 0
TOTAL EQUITY $1,800 $100 $730 $2,630
TOTAL LIABILITIES & EQUITY $2,800 $310 $1,248 $4,358
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
KEY BALANCE SHEET METRICS
Total Debt $1,100
Cash $180
Net Debt $920
Book Value of Equity $2,630
Shares Outstanding (M) 123.0
Book Value per Share $21.38
Debt / Equity 41.8%
Debt / Total Capitalization 29.5%
SECTION 6: Credit Metrics & Leverage Analysis
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
CREDIT METRICS ANALYSIS
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
Year 1 Year 2 Year 3 Year 4 Year 5
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
EBITDA CALCULATION
Pro Forma EBIT $594 $759 $911 $1,072 $1,249
+ Pro Forma D&A 193 205 218 225 241
Pro Forma EBITDA $787 $964 $1,129 $1,297 $1,490
DEBT SCHEDULE
Beginning Debt Balance $1,100 $1,045 $985 $920 $850
Mandatory Amortization (50) (55) (60) (65) (70)
Optional Prepayment (5) (5) (5) (5) (5)
Ending Debt Balance $1,045 $985 $920 $850 $775
Average Debt $1,073 $1,015 $953 $885 $813
Interest Expense @ 5.0% $50 $50 $48 $46 $44
LEVERAGE RATIOS
Total Debt / EBITDA 1.3x 1.0x 0.8x 0.7x 0.5x
Net Debt / EBITDA 1.2x 0.9x 0.7x 0.5x 0.4x
Target Covenant: < 3.5x โ โ โ โ โ
COVERAGE RATIOS
EBITDA / Interest 15.7x 19.3x 23.5x 28.2x 33.9x
EBIT / Interest 11.9x 15.2x 19.0x 23.3x 28.4x
(EBITDA - Capex) / Interest 13.1x 16.5x 20.3x 24.7x 29.9x
Target Covenant: >> 3.0x โ โ โ โ โ
FREE CASH FLOW METRICS
EBITDA $787 $964 $1,129 $1,297 $1,490
- Cash Interest (50) (50) (48) (46) (44)
- Cash Taxes (136) (177) (216) (257) (301)
- Capex (132) (145) (163) (181) (201)
- Change in NWC (15) (18) (20) (23) (25)
Unlevered Free Cash Flow $454 $574 $682 $790 $919
- Debt Amortization (55) (60) (65) (70) (75)
Levered Free Cash Flow $399 $514 $617 $720 $844
FCF / Total Debt 38.2% 52.2% 67.1% 84.7% 108.9%
FCF Yield on Purchase Price 26.6% 34.3% 41.1% 48.0% 56.3%
RETURNS METRICS
ROIC (Unlevered):
NOPAT $446 $570 $684 $804 $937
Invested Capital $1,500 $1,500 $1,500 $1,500 $1,500
ROIC 29.7% 38.0% 45.6% 53.6% 62.5%
ROE:
Net Income $408 $532 $647 $770 $904
Avg. Shareholders' Equity $2,215 $2,630 $2,630 $2,630 $2,630
ROE 18.4% 20.2% 24.6% 29.3% 34.4%
SECTION 7: Sensitivity Analysis Tables
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
SENSITIVITY ANALYSIS
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
TABLE 1: PURCHASE PRICE vs. ACCRETION (Year 1)
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
Purchase Price ($M)
Stock/Cash Mix $1,300 $1,400 $1,500 $1,600 $1,700
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
100% Stock (8.2%) (11.5%) (14.9%) (18.1%) (21.2%)
75% Stock (9.5%) (12.9%) (16.3%) (19.6%) (22.8%)
50% Stock (11.1%) (14.6%) (18.0%) (21.3%) (24.6%)
25% Stock (13.2%) (16.8%) (20.3%) (23.7%) (27.0%)
100% Cash (16.8%) (20.5%) (24.1%) (27.6%) (31.0%)
Note: All-stock less dilutive short-term, but all-cash preserves
future upside for existing shareholders
TABLE 2: SYNERGIES vs. YEAR 3 ACCRETION
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
Cost Synergies Realized ($M)
Revenue Syn. $20 $30 $40 $50 $60
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
$0 (12.1%) (7.3%) (2.5%) 2.3% 7.1%
$15 (9.8%) (5.0%) (0.2%) 4.6% 9.4%
$30 (7.5%) (2.7%) 2.1% 6.9% 11.7%
$45 (5.2%) (0.4%) 4.4% 9.2% 14.0%
$60 (2.9%) 1.9% 6.7% 11.5% 16.3%
Base Case Assumptions: $33M cost synergies, $28M revenue synergies
TABLE 3: ACQUIRER STOCK PRICE vs. YEAR 1 ACCRETION
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
Acquirer Stock Price at Close
% Stock Used $35 $40 $45 $50 $55
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
40% (14.2%) (15.1%) (16.6%) (18.5%) (20.8%)
50% (13.8%) (14.8%) (16.3%) (18.2%) (20.5%)
60% (13.3%) (14.4%) (15.9%) (17.9%) (20.2%)
70% (12.9%) (14.0%) (15.6%) (17.5%) (19.9%)
80% (12.4%) (13.6%) (15.2%) (17.2%) (19.5%)
Lower stock price = More shares issued = More dilution
Higher stock price = Fewer shares issued = Less dilution
TABLE 4: INTEGRATION COSTS vs. NET SYNERGIES (NPV)
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
Integration Costs ($M)
Synergies $25 $35 $45 $55 $65
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
$50 Run-Rate $208 $198 $188 $178 $168
$60 Run-Rate $258 $248 $238 $228 $218
$70 Run-Rate $308 $298 $288 $278 $268
$80 Run-Rate $358 $348 $338 $328 $318
$90 Run-Rate $408 $398 $388 $378 $368
NPV = PV of synergies over 5 years @ 11% WACC - Integration Costs
Base Case: $61M run-rate synergies, $40M integration costs = $238M NPV
TABLE 5: BREAK-EVEN ANALYSIS
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
To achieve Year 1 EPS accretion-neutral ($3.98):
OPTION 1: Reduce Purchase Price
Maximum EV: $1,285M
Implied EBITDA Multiple: 16.1x
Current Offer: 19.4x
Required Discount: 17%
OPTION 2: Increase Synergies
Required Additional Cost Synergies: $52M (vs. $33M base)
Increase Required: 58%
OPTION 3: Change Financing Mix
Required % Cash (vs. 40% base): 72%
Additional Debt Required: $480M
Pro Forma Leverage: 4.1x (vs. 1.3x base)
OPTION 4: Combination Approach
Purchase Price: $1,400M (-7%)
Cost Synergies: $42M (+27%)
% Cash: 50% (+10pp)
Result: ~0% Y1 Accretion
SECTION 8: Alternative Deal Structure Scenarios
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
DEAL STRUCTURE COMPARISON
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
Scenario A Scenario B Scenario C
All Stock 50/50 Mix All Cash
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
DEAL TERMS
Purchase Price ($M) $1,500 $1,500 $1,500
Stock Consideration 100% 50% 0%
Cash Consideration 0% 50% 100%
FINANCING
New Debt ($M) $100 $850 $1,600
Stock Issued ($M) $1,500 $750 $0
Cash Used ($M) $30 $30 $30
New Shares Issued (M) 33.3 16.7 0.0
Pro Forma Shares (M) 136.3 119.7 103.0
YEAR 1 FINANCIALS
Pro Forma EBIT $594 $594 $594
Interest Expense (10) (48) (88)
EBT 584 546 506
Taxes @ 25% (146) (137) (127)
Net Income $438 $410 $380
EPS $3.21 $3.42 $3.69
Standalone EPS $3.98 $3.98 $3.98
Accretion/(Dilution) (19.3%) (14.1%) (7.3%)
YEAR 3 FINANCIALS
Pro Forma EBIT $911 $911 $911
Interest Expense (8) (43) (78)
EBT 903 868 833
Net Income $677 $651 $625
EPS $4.97 $5.44 $6.07
Standalone EPS $5.45 $5.45 $5.45
Accretion/(Dilution) (8.8%) (0.2%) 11.4%
CREDIT METRICS (Year 1)
Total Debt $600 $1,350 $2,100
EBITDA $787 $787 $787
Debt / EBITDA 0.8x 1.7x 2.7x
EBIT / Interest 59.4x 12.4x 6.8x
Rating Implication AA A BBB+
Cost of Debt 4.00% 5.00% 6.00%
STRATEGIC CONSIDERATIONS
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
Scenario A (All Stock):
โ Minimal debt, pristine balance sheet
โ Maximum financial flexibility
โ Aligns incentives (target shareholders stay invested)
โ Significant dilution (25% more shares)
โ Deal value fluctuates with stock price
โ Most dilutive to existing shareholders
Scenario B (50/50 Mix):
โ Balanced approach
โ Moderate leverage
โ Manageable dilution (16% more shares)
โ Maintains investment grade rating
โ Moderate risk/return profile
Scenario C (All Cash):
โ No share dilution
โ Fixed deal value
โ Highest near-term EPS (lowest share count)
โ High leverage (2.7x)
โ Constrains financial flexibility
โ Higher interest burden
โ May require asset sales or equity raise later
RECOMMENDATION: Scenario B (50/50 Mix) offers best balance
SECTION 9: Deal Summary Dashboard
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
EXECUTIVE SUMMARY METRICS
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
TRANSACTION OVERVIEW
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
Target Company: TargetCo
Purchase Price: $1,500M
Enterprise Value: $1,550M
Financing: 60% Stock / 40% Debt+Cash
Expected Close: Q2 2025
VALUATION
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
EV / LTM Revenue: 3.9x
EV / LTM EBITDA: 19.4x
EV / LTM EBIT: 25.8x
Premium to Market Price: 25.0%
Benchmark Median Multiples:
Public Comps EV/EBITDA: 17.5x [Above]
Recent M&A EV/EBITDA: 18.2x [Above]
STRATEGIC RATIONALE
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
1. Expand addressable market by $2.5B
2. Accelerate product roadmap by 18-24 months
3. Gain 350 enterprise customers
4. Achieve #1 or #2 market position in 3 verticals
5. Realize $61M annual run-rate synergies
FINANCIAL IMPACT (Year 1 โ Year 3)
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
Year 1 Year 3
Revenue $2,660M $3,270M
Growth Rate 10.8% 10.9%
EBITDA $787M $1,129M
Margin 29.6% 34.5%
EPS (Pro Forma) $3.32 $5.26
Accretion/(Dilution) (16.6%) (3.5%)
Free Cash Flow $399M $617M
FCF Yield 26.6% 41.1%
RETURNS ANALYSIS
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
5-Year IRR on Investment: 17.8%
Year 3 ROIC: 45.6%
Year 5 ROIC: 62.5%
Payback Period (undiscounted): 3.2 years
NPV of Synergies (@ 11% WACC): $238M
NPV of Deal (vs. $1,500M price): Positive if synergies >> 85%
RISK FACTORS & MITIGANTS
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
Risk Mitigation
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
Integration complexity Dedicated PMO team, 100-day plan
Customer churn (10% modeled) Retention bonuses, customer success
Key talent retention Stay bonuses for top 50 employees
Synergy realization (85% prob) Conservative phasing, external advisors
Regulatory approval Pre-filing with FTC, clean Hart-Scott
CREDIT PROFILE
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
Pro Forma Debt / EBITDA: 1.3x
Interest Coverage: 15.7x
Pro Forma Rating: A (Stable)
Covenant Headroom:
Max Leverage (3.5x): 2.2x headroom โ
Min Interest Coverage (3.0x): 12.7x headroom โ
GOVERNANCE & APPROVALS
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
Board Approval Required: Yes (>$1B transaction)
Shareholder Vote Required: Yes (>20% dilution)
Regulatory Approvals: Hart-Scott-Rodino (HSR)
Expected Vote Support: 75%+ (based on investor calls)
GO / NO-GO DECISION CRITERIA
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
Criterion Target Actual Status
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
EV/EBITDA < 20x <20x 19.4x โ PASS
Year 3 Accretive >>0% (3.5%) โ MISS
Debt/EBITDA < 2.5x <2.5x 1.3x โ PASS
ROIC > WACC by Year 3 >>11% 45.6% โ PASS
Synergy NPV > $200M >>$200M $238M โ PASS
Strategic Fit Score >>8/10 9/10 โ PASS
Integration Risk Medium Medium โ PASS
Overall Assessment: PROCEED
(6 of 7 pass)
SECTION 10: Model Usage Instructions
Step 1: Input Collection
Fill in all blue-highlighted cells in Section 1 (Transaction Assumptions). Ensure you have:
โข Audited financials for both companies (3 years historical)
โข Management projections
โข Current stock prices and share counts
โข Debt terms and schedules
โข Quality of earnings adjustments
Step 2: PPA Development
Work with external valuation firm or accounting team to:
โข Identify all intangible assets
โข Determine fair values
โข Assign useful lives
โข Calculate deferred tax impacts
Step 3: Synergy Validation
Build bottom-up synergy analysis:
โข Interview functional leaders (HR, IT, Facilities, Ops)
โข Get specific headcount reduction lists
โข Model revenue synergies conservatively
โข Account for dis-synergies (churn, disruption)
โข Estimate integration costs and timing
Step 4: Scenario Analysis
Build 3 cases (Base, Upside, Downside):
โข Vary key assumptions (growth, synergies, price)
โข Stress test financing structures
โข Run sensitivities on critical variables
โข Calculate break-even thresholds
Step 5: Validation & Review
Before presenting:
โข Verify all formulas link correctly
โข Check that balance sheet balances
โข Confirm sources = uses
โข Review reasonableness of all metrics
โข Compare to comparable transactions
โข Prepare answers to obvious objections
Common Checks
โ Pro forma shares = Acquirer shares + New shares issued
โ PPA intangibles + Goodwill = Purchase price - Fair value of net assets
โ Interest expense = Average debt ร Interest rate
โ Taxes = Pre-tax income ร Effective tax rate
โ Cash flow statement ties to balance sheet changes
โ All percentages sum to 100% where applicable
โ No #REF, #DIV/0, or #VALUE errors
Model Maintenance Best Practices
Version Control:
- Save dated versions (MergerModel_2025-01-30_v1.xlsx)
- Track major assumption changes in change log
- Use Excel's "Track Changes" for collaborative reviews
- Maintain separate tabs for each scenario
Documentation:
- Add comments to all key assumption cells
- Document data sources (where did this number come from?)
- Explain any unusual adjustments
- Keep supporting schedules organized
Flexibility:
- Use named ranges for key inputs
- Build dropdown menus for scenarios
- Color code: Blue = Input, Black = Formula, Green = Link
- Avoid hard-coding; use cell references
Presentation:
- Keep output tabs clean and print-friendly
- Use conditional formatting for quick insights
- Build executive summary dashboard
- Create board-ready charts and graphs
Updates:
- Refresh model as new information arrives
- Update market data (stock prices, interest rates) daily during active negotiations
- Adjust synergies based on due diligence findings
- Revise timing assumptions as integration planning progresses
References
- Rosenbaum & Pearl - Investment Banking: Valuation, LBOs, M&A, and IPOs
- M&A Modeling - Wall Street Prep
- Accretion/Dilution Analysis - Corporate Finance Institute
- Purchase Price Allocation - Deloitte M&A Accounting Guide
- Merger Consequences - McKinsey on M&A
- ASC 805 Business Combinations - FASB
- Credit Metrics for M&A - S&P Global Ratings
- Merger Model Best Practices - EY M&A Valuations
Last updated: Wed Jan 29 2025 19:00:00 GMT-0500 (Eastern Standard Time)